In part 2 of our interview with Surbhi Sidana, MD, MBBS, American Society of Hematology and Stanford University, she delves ...

At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at ...

Of the 10% of women contacted for this survey who said that they or their partner had ever sought fertility assistance, only ...

There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, ...

A machine-learning model developed in this study was able to predict 24-hour peaks for intraocular pressure (IOP).

Various therapies have different impacts on brain volume loss in patients with relapsing multiple sclerosis (MS), a new study ...

Medicaid expansion improved 2-year survival rates and access to guideline-concordant treatment for patients with HR-negative ...

Moderate prediagnosis adherence to dietary guidelines was associated with improved survival rates among Black women with high-grade serous ovarian cancer, the most common and lethal type of ovarian ...

Payers and providers face challenges surrounding data integration, patient engagement, and financial pressures when trying to ...

Etonogestrel-releasing contraceptive implants in women with sickle cell disease significantly reduced pain intensity and ...

Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.

A pioneering program targeting gut microbiome health significantly reduces cancer treatment side effects, enhancing patient well-being and resilience.